BURGALASSI, SUSI Statistiche
BURGALASSI, SUSI
DIPARTIMENTO DI FARMACIA
"In vitro" Alternative Methods for Evaluation of Ocular Toxicity
1999-01-01 Monti, Daniela; Chetoni, Patrizia; Burgalassi, Susi; Malvaldi, M. E.; Saettone, M. F.
4-Methylbenzylidene camphor microspheres: Reconstituted epidermis (Skinethic®) permeation and distribution
2015-01-01 Monti, Daniela; Chetoni, Patrizia; Burgalassi, Susi; Tampucci, Silvia; Centini, M.; Anselmi, C.
[Formulation and stability of suspensions for preclinical study]. Formulazione e stabilità di sospensioni per studi preclinici.
1997-01-01 Burgalassi, Susi; Perini, G; Giannaccini, B; Saettone, MARCO FABRIZIO; Lodi, A.
A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test
2003-01-01 Huhtala, A; Alajuuma, P; Burgalassi, Susi; Chetoni, Patrizia; Diehl, H; Engelke, M; Marselos, M; Monti, Daniela; Pappas, P; Saettone, MARCO FABRIZIO; Salmimen, L; Sotiropoulou, M; Tahti, H; Uusitalo, H; Zornkruppa, M.
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome
2016-01-01 Richichi, B; Baldoneschi, V.; Burgalassi, Susi; Fragai, M.; Vullo, D.; Akdemir, A.; Dragoni, E.; Louka, A.; Mamusa, M.; Monti, Daniela; Berti, D.; Novellino, E.; Rosa, G. De; Supuran, C. T.; Nativi, C.
A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability
2021-01-01 Terreni, E.; Chetoni, P.; Burgalassi, S.; Tampucci, S.; Zucchetti, E.; Chipala, E.; Alany, R. G.; Al-Kinani, A. A.; Monti, D.
A new liquid formulation containing indomethacin: evaluation of the chemical stability and of the anti-inflammatory activity in rabbits
1997-01-01 Chetoni, Patrizia; Panichi, L; Burgalassi, Susi; Lucchesi, L; Saettone, Mf; Benelli, U.
A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone
2018-01-01 Piras, Anna Maria; Zambito, Ylenia; Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Terreni, Eleonora; Fabiano, Angela; Balzano, Federica; Uccello-Barretta, Gloria; Chetoni, Patrizia
Aloe purificata: formulazioni oftalmiche
2006-01-01 Sommani, C; Burgalassi, Susi; Monti, Daniela; Najarro, M; Chetoni, Patrizia
Aloe vera as ophthalmic drug delivery: preliminary evaluation
2006-01-01 Burgalassi, Susi; Sommani, C.; Monti, Daniela; Chetoni, Patrizia
Aqueous ophthalmic formulations containing formocortal solubilised by surfactants or complexing agents
1998-01-01 Panichi, L; Chetoni, Patrizia; Burgalassi, Susi; Boldrini, E; Saettone, Mf
Arabinogalactan (AG) in dry eye age-related: a new mucoadhesive and no-viscous ophthalmic vehicle with protective effect on corneal epithelium. Experimental studies.
2007-01-01 G., Falcone; Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; E., Boldrini
Arabinogalactan as active compound in the management of corneal wounds: In vitro toxicity and in vivo investigations on rabbits
2011-01-01 Burgalassi, Susi; Nicosia, Nadia; Monti, Daniela; Falcone, Giulia; Boldrini, Enrico; Fabiani, Ortenzio; Lenzi, Carla; Pirone, Andrea; Chetoni, Patrizia
Arabinogalactan in the Re-Epithelization and Glycocalyx Restoration Process of Rabbit Damaged Corneas
2008-01-01 G., Falcone; Pirone, Andrea; Lenzi, Carla; Fabiani, Ortenzio; Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; E., Boldrini
Arabinogalactan: a new ophthalmic vehicle for dry eye protection and treatment of corneal lesions
2007-01-01 Burgalassi, Susi; N., Nicosia; Monti, Daniela; G., Falcone; E., Boldrini; Chetoni, Patrizia
Arabinogalattano per uso oculare: caratterizzazione ed efficacia nel processo di riepitelizzazione corneale.
2009-01-01 Burgalassi, Susi; Nicosia, N; Monti, Daniela; Falcone, G; Boldrini, E; Chetoni, Patrizia
Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A
2020-01-01 Terreni, E.; Chetoni, P.; Tampucci, S.; Burgalassi, S.; Al-Kinani, A. A.; Alany, R. G.; Monti, D.
Buccal delivery of lorazepam: permeation studies across human epithelial cells “in vitro”
2000-01-01 Burgalassi, Susi; Chetoni, Patrizia; Dini, L; Santarelli, D; Monti, Daniela
Caratterizzazione chimico-fisica di polimeri ad uso farmaceutico per la valutazione delle loro caratteristiche mucoadesive
2012-01-01 Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Chetoni, Patrizia
Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies
2004-01-01 M. C., Bonferoni; Chetoni, Patrizia; P., Giunchedi; S., Rossi; F., Ferrari; Burgalassi, Susi; C., Caramella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "In vitro" Alternative Methods for Evaluation of Ocular Toxicity | 1-gen-1999 | Monti, Daniela; Chetoni, Patrizia; Burgalassi, Susi; Malvaldi, M. E.; Saettone, M. F. | |
| 4-Methylbenzylidene camphor microspheres: Reconstituted epidermis (Skinethic®) permeation and distribution | 1-gen-2015 | Monti, Daniela; Chetoni, Patrizia; Burgalassi, Susi; Tampucci, Silvia; Centini, M.; Anselmi, C. | |
| [Formulation and stability of suspensions for preclinical study]. Formulazione e stabilità di sospensioni per studi preclinici. | 1-gen-1997 | Burgalassi, Susi; Perini, G; Giannaccini, B; Saettone, MARCO FABRIZIO; Lodi, A. | |
| A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test | 1-gen-2003 | Huhtala, A; Alajuuma, P; Burgalassi, Susi; Chetoni, Patrizia; Diehl, H; Engelke, M; Marselos, M; Monti, Daniela; Pappas, P; Saettone, MARCO FABRIZIO; Salmimen, L; Sotiropoulou, M; Tahti, H; Uusitalo, H; Zornkruppa, M. | |
| A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome | 1-gen-2016 | Richichi, B; Baldoneschi, V.; Burgalassi, Susi; Fragai, M.; Vullo, D.; Akdemir, A.; Dragoni, E.; Louka, A.; Mamusa, M.; Monti, Daniela; Berti, D.; Novellino, E.; Rosa, G. De; Supuran, C. T.; Nativi, C. | |
| A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability | 1-gen-2021 | Terreni, E.; Chetoni, P.; Burgalassi, S.; Tampucci, S.; Zucchetti, E.; Chipala, E.; Alany, R. G.; Al-Kinani, A. A.; Monti, D. | |
| A new liquid formulation containing indomethacin: evaluation of the chemical stability and of the anti-inflammatory activity in rabbits | 1-gen-1997 | Chetoni, Patrizia; Panichi, L; Burgalassi, Susi; Lucchesi, L; Saettone, Mf; Benelli, U. | |
| A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone | 1-gen-2018 | Piras, Anna Maria; Zambito, Ylenia; Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Terreni, Eleonora; Fabiano, Angela; Balzano, Federica; Uccello-Barretta, Gloria; Chetoni, Patrizia | |
| Aloe purificata: formulazioni oftalmiche | 1-gen-2006 | Sommani, C; Burgalassi, Susi; Monti, Daniela; Najarro, M; Chetoni, Patrizia | |
| Aloe vera as ophthalmic drug delivery: preliminary evaluation | 1-gen-2006 | Burgalassi, Susi; Sommani, C.; Monti, Daniela; Chetoni, Patrizia | |
| Aqueous ophthalmic formulations containing formocortal solubilised by surfactants or complexing agents | 1-gen-1998 | Panichi, L; Chetoni, Patrizia; Burgalassi, Susi; Boldrini, E; Saettone, Mf | |
| Arabinogalactan (AG) in dry eye age-related: a new mucoadhesive and no-viscous ophthalmic vehicle with protective effect on corneal epithelium. Experimental studies. | 1-gen-2007 | G., Falcone; Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; E., Boldrini | |
| Arabinogalactan as active compound in the management of corneal wounds: In vitro toxicity and in vivo investigations on rabbits | 1-gen-2011 | Burgalassi, Susi; Nicosia, Nadia; Monti, Daniela; Falcone, Giulia; Boldrini, Enrico; Fabiani, Ortenzio; Lenzi, Carla; Pirone, Andrea; Chetoni, Patrizia | |
| Arabinogalactan in the Re-Epithelization and Glycocalyx Restoration Process of Rabbit Damaged Corneas | 1-gen-2008 | G., Falcone; Pirone, Andrea; Lenzi, Carla; Fabiani, Ortenzio; Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; E., Boldrini | |
| Arabinogalactan: a new ophthalmic vehicle for dry eye protection and treatment of corneal lesions | 1-gen-2007 | Burgalassi, Susi; N., Nicosia; Monti, Daniela; G., Falcone; E., Boldrini; Chetoni, Patrizia | |
| Arabinogalattano per uso oculare: caratterizzazione ed efficacia nel processo di riepitelizzazione corneale. | 1-gen-2009 | Burgalassi, Susi; Nicosia, N; Monti, Daniela; Falcone, G; Boldrini, E; Chetoni, Patrizia | |
| Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A | 1-gen-2020 | Terreni, E.; Chetoni, P.; Tampucci, S.; Burgalassi, S.; Al-Kinani, A. A.; Alany, R. G.; Monti, D. | |
| Buccal delivery of lorazepam: permeation studies across human epithelial cells “in vitro” | 1-gen-2000 | Burgalassi, Susi; Chetoni, Patrizia; Dini, L; Santarelli, D; Monti, Daniela | |
| Caratterizzazione chimico-fisica di polimeri ad uso farmaceutico per la valutazione delle loro caratteristiche mucoadesive | 1-gen-2012 | Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Chetoni, Patrizia | |
| Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies | 1-gen-2004 | M. C., Bonferoni; Chetoni, Patrizia; P., Giunchedi; S., Rossi; F., Ferrari; Burgalassi, Susi; C., Caramella |